Nevertheless, ET and PV patients with the TET2 mutation had a significantly higher baseline JAK2V617F allele burden compared with TET2 wild type cases as reported in the serial single gene sequencing study of 40 ET and 43 PV JAK2V617F positive patients performed by Quintas-Cardama et al. [198]. This evidence concerns the gene TET2 and essential thrombocythemia.